Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 58 Neoplasms 51 Lung Neoplasms 33 Colorectal Neoplasms 28 Carcinoma, Non-Small-Cell Lung 25 Prostatic Neoplasms 22 Melanoma 19 Pancreatic Neoplasms 17 Ovarian Neoplasms 16 Uterine Cervical Neoplasms 14 Sarcoma 12 Multiple Myeloma 12 Lymphoma 11 Glioma 11 Glioblastoma 11 Neoplasm Metastasis 10 Leukemia, Myeloid, Acute 10 Colonic Neoplasms 10 Neoplastic Cells, Circulating 9 Hematologic Neoplasms 9 Lymphoma, Follicular 8 Head and Neck Neoplasms 8 Carcinoma, Hepatocellular 8 Leukemia 7 Brain Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Papillomavirus Infections 6 Myelodysplastic Syndromes 6 Endometrial Neoplasms 6 Disease 6

Interventions

Endoscopy 13 Endoscopy, Digestive System 12 Radiofrequency Ablation 7 Esomeprazole 7 Biopsy 7 Endoscopic Mucosal Resection 6 Specimen Handling 4 Proflavine 4 Omeprazole 4 Aspirin 4 Gastroscopy 3 YF 476 2 Proton Pump Inhibitors 2 Photochemotherapy 2 Narrow Band Imaging 2 Microscopy, Confocal 2 Metformin 2 Lansoprazole 2 Itraconazole 2 Endoscopes 2 Diagnostic Imaging 2 Dexlansoprazole 2 Cryotherapy 2 Cryosurgery 2 Breath Tests 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 rofecoxib 1 polyphenon E 1 plecanatide 1 omeprazole, sodium bicarbonate drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Barrett Esophagus × Blood Specimen Collection × Clear all

NCT01209013 2012-05-08

Oedisse

Pinnacle Biologics Inc.

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡